TauRx boost for Genting


Likely catalyst: People pass a Genting signage at a hotel in Singapore. The potential listing of Genting’s 20.7-owned TauRx on Nasdaq may provide a catalyst to Genting’s share price. – Reuters

Casino operator may gain from share in drug company

PETALING JAYA: The potential listing of Genting Bhd’s 20.7%-owned Alzheimer’s drugs company on Nasdaq could provide a catalyst to the share price of the Malaysian conglomerate.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Cautious tone expected for ringgit versus US dollar trading next week
U Mobile to reduce foreign majority shareholdings to 20%
MACC investigating Khazanah, PNB's unsuccessful investment
Another data centre job for Gamuda
SOBA judges, past winners share winning tips
Government and venture capital
Selling pressure amid Mideast and polls anxiety
Low volatility a remedy for the extremes?
Maximising your unit trust returns
Dishing up consumer success

Others Also Read